Evidence map›Paper›PMID 34292487›Full record

ArticleJournal of autism and developmental disorders2023

The Cost of Raising Individuals with Fragile X or Chromosome 15 Imprinting Disorders in Australia.

Emma K Baker, Sheena Arora, David J Amor, Perrin Date, Meagan Cross, James O'Brien, Chloe Simons, Carolyn Rogers, Stephen Goodall, Jennie Slee and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of autism and developmental disorders, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Emma K BakerDiagnosis and Development, Murdoch Children's Research Institute, Royal Children's Hospital, 50 Flemington Road, Parkville, VIC, 3052, Australia.
Sheena AroraCentre for Health Economics Research and Evaluation, University of Technology Sydney, Broadway, NSW, Australia.
David J AmorFaculty of Medicine, Dentistry and Health Sciences, Department of Paediatrics, University of Melbourne, Parkville, VIC, Australia.
Perrin DateDiagnosis and Development, Murdoch Children's Research Institute, Royal Children's Hospital, 50 Flemington Road, Parkville, VIC, 3052, Australia.
Meagan CrossFoundation for Angelman Syndrome Therapeutics (FAST), Salisbury, QLD, Australia.
James O'BrienPrader-Willi Syndrome Australia Ltd, Melbourne, VIC, Australia.
Chloe SimonsFoundation for Angelman Syndrome Therapeutics (FAST), Salisbury, QLD, Australia.
Carolyn RogersGenetics of Learning Disability Service, Hunter Genetics, Waratah, NSW, Australia.
Stephen GoodallCentre for Health Economics Research and Evaluation, University of Technology Sydney, Broadway, NSW, Australia.
Jennie SleeDepartment of Health, Government of Western Australia, Genetic Services of Western Australia, Perth, WA, Australia.
Chris CahirDup15q Australia Ltd, Melbourne, VIC, Australia.
David E GodlerDiagnosis and Development, Murdoch Children's Research Institute, Royal Children's Hospital, 50 Flemington Road, Parkville, VIC, 3052, Australia. david.godler@mcri.edu.au.

Funding

Financial Markets Foundation for Children 2017 - 361Medical Research Future Fund MRF1141334National Health and Medical Research Council 1049299National Health and Medical Research Council 1103389
6 · The paper itself

Abstract

The study characterised differences in costs associated with raising a child between four rare disorders and examined the associations between these costs with clinical severity. Caregivers of 108 individuals with Prader-Willi, Angelman (AS), Chromosome 15q Duplication and fragile X (FXS) syndromes completed a modified Client Services Receipt Inventory and participants completed intellectual/developmental functioning and autism assessments. AS incurred the highest yearly costs per individual ($AUD96,994), while FXS had the lowest costs ($AUD33,221). Intellectual functioning negatively predicted total costs, after controlling for diagnosis. The effect of intellectual functioning on total costs for those with AS was significantly different to the other syndromes. The study highlights the significant costs associated with these syndromes, particularly AS, linked with severity of intellectual functioning.

Indexed as

Angelman SyndromeAutism Spectrum DisorderFragile X SyndromePrader-Willi SyndromeAustraliaChildChromosome DuplicationChromosomes, Human, Pair 15HumansAngelman syndromeChromosome 15 Duplication syndromeFragile X syndromeHealth EconomicsPrader-Willi syndrome

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.